Cell to Cell Signaling and Depression

ATP and Your Brain
A recent article in Molecular Psychiatrydoi:10.1038/mp.2017.229 elucidates the role of ATP and Neuron-Glial interactions in depression.

This study also features the use of our excellent GFAP markers

Abstract: Extracellular ATP is a widespread cell-to-cell signaling molecule in the brain, where it functions as a neuromodulator by activating glia and neurons. Although ATP exerts multiple effects on synaptic plasticity and neuro-glia interactions, as well as in mood disorders, the source and regulation of ATP release remain to be elaborated. Here, we define Calhm2 as an ATP-releasing channel protein based on in vitro and in vivo models. Conventional knockout and conditional astrocyte knockout of Calhm2 both lead to significantly reduced ATP concentrations, loss of hippocampal spine number, neural dysfunction and depression-like behaviors in mice, which can be significantly rescued by ATP replenishment. Our findings identify Calhm2 as a critical ATP-releasing channel that modulates neural activity and as a potential risk factor of depression.

Big Thank You!

Big Year
We exceeded our goals for 2017. By a lot. Both in sales and new products.

I would like to personally thank our customers, collaborators, and friends for making this happen. You made it happen.

I wish Joy to you in 2018!

I wish you exciting, new discoveries, and adventures.

Pete Shuster, CEO and Owner, Neuromics.

Coming Soon Hepatocytes and CSCS

Differentiated from iPSCs

Neuromics is partnering with Javeen Biosciences to bring you Cancer Stem Cells and Hepatocytes derived from donor Induced Pluripotent Stem Cells.

Rodney Nash, Javeen CEO, and his team are working to fill a major gap in cell-based drug discoveries. The lack of cells from specific diseased or ethnic populations. This limits the ability to predict how well a drug candidate will work with a diverse population of patients.

Dr. Rodney Nash, CEO, Javeen Biosciences

Over time, we envision Javeen Biosciences as having the ability to engineer cells from donors that match tightly with the needs of drug hunters.

We ask you to "Think of 8". This video illustrates the power Javeen Biosciences' solutions

Much more to follow...